CAHC

NASDAQ

CA Healthcare Acquisition Corp.

News25/Ratings2

CA Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more operating businesses. CA Healthcare Acquisition Corp. was founded in 2020 and is based in Boston, Massachusetts.

Latest news

25 items

1654dSEC
SEC Form 15-12B filed by CA Healthcare Acquisition Corp.
15-12B - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1662dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1668dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1668dPR
LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp.
LumiraDx's common shares will commence trading on September 29, 2021 on Nasdaq under the ticker symbol "LMDX" The Merger values LumiraDx at $3.0 billion (excluding the amounts raised by CAHC in its initial public offering) LumiraDx Limited ("LumiraDx"), a next-generation point of care ("POC") diagnostic testing company and CA Healthcare Acquisition Corp. ("CAHC"), a special purpose acquisition company traded on Nasdaq, today announced the completion of the previously announced merger. CAHC stockholders approved the merger (the "Merger") during a special meeting held today and final voting results will be disclosed by CAHC on a Form 8-K to be filed with the Securities and Exchange Comm
1672d13D/G
SEC Form SC 13G filed by CA Healthcare Acquisition Corp.
SC 13G - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1673dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1673dSEC
SEC Form 425 filed by CA Healthcare Acquisition Corp.
425 - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1673dSEC
SEC Form DEFA14A filed by CA Healthcare Acquisition Corp.
DEFA14A - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1686dSEC
SEC Form DEFA14A filed by CA Healthcare Acquisition Corp.
DEFA14A - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1689dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1689dSEC
SEC Form 425 filed by CA Healthcare Acquisition Corp.
425 - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1689dPR
CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination
CA Healthcare's Board Recommends Stockholders Vote "FOR" the Business Combination and "FOR" all of the related proposals All stockholders of CA Healthcare as of September 1st, 2021 are encouraged to vote their shares in advance of the Special Meeting Stockholders who need assistance voting their shares should contact CA Healthcare's proxy solicitor, Morrow Sodali, at 203-658-9400 or via email at cahc@info.morrowsodali.com CA Healthcare Acquisition Corp. (NASDAQ:CAHC) ("CA Healthcare"), a publicly traded special purpose acquisition company, and LumiraDx Limited ("LumiraDx"), a next-generation point of care diagnostics testing company, announced that the U.S. Securities and Exchange Commis
1693dSEC
SEC Form DEFM14A filed by CA Healthcare Acquisition Corp.
DEFM14A - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1696dANALYST
Ladenburg Thalmann initiated coverage on CA Healthcare Acquisition
Ladenburg Thalmann initiated coverage of CA Healthcare Acquisition with a rating of Buy
1696dANALYST
Ladenburg Thalmann initiated coverage on Compost America Holding with a new price target
Ladenburg Thalmann initiated coverage of Compost America Holding with a rating of Buy and set a new price target of $14.75
1697dSEC
SEC Form 425 filed by CA Healthcare Acquisition Corp.
425 - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1697dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1707dSEC
SEC Form 425 filed by CA Healthcare Acquisition Corp.
425 - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1707dSEC
SEC Form 425 filed by CA Healthcare Acquisition Corp.
425 - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1707dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1707dPR
LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics
Revised transaction terms adjust LumiraDx's pro forma valuation for the combined group from $5 billion to $3 billion (excluding $115 million raised by CA Healthcare Acquisition Corp ("CAHC") in its initial public offering). Terms establish a more attractive entry point for investors, and a highly compelling investment thesis on an absolute and relative basis Factors considered in revising the valuation include: the recent market environment for publicly traded diagnostic companies, general decline in COVID-19 testing market, and feedback from CAHC's advisors and shareholders LumiraDx has a roadmap of 10 new test approvals over the next 24 months on its platform, including Troponin,
1742dSEC
CA Healthcare Acquisition Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1742dSEC
SEC Form 425 filed by CA Healthcare Acquisition Corp.
425 - CA Healthcare Acquisition Corp. (0001832352) (Subject)
1793dSEC
SEC Form 10-Q/A filed by CA Healthcare Acquisition Corp. (Amendment)
10-Q/A - CA Healthcare Acquisition Corp. (0001832352) (Filer)
1795dSEC
SEC Form 10-Q filed by CA Healthcare Acquisition Corp.
10-Q - CA Healthcare Acquisition Corp. (0001832352) (Filer)